Fingolimod, a drug manufactured by Novartis under the brand name Gilenya, is a U.S. Food and Drug Administration (FDA)-approved treatment for symptoms of relapsing forms of multiple sclerosis (MS). It is immunomodulatory in nature and works to reduce MS exacerbations and delay progression toward disability.
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?